Showing results (1841-1850 of 2,028) with videos related to

Sort By:
Pageof 203
Journal of Occupational and Environmental Medicine|February 2, 2023
Assessing the Mental Health Impact of the COVID-19 Pandemic on US Fire-Based Emergency Medical Services Responders: A Tale of Two Samples (The RAPID Study I)Madison E Raposa, Gabrielle Mullin, Regan M Murray, et al.
Breast Cancer Research and Treatment|January 1, 1981
Correlation of primary breast cancer histopathology and estrogen receptor contentE R Fisher, C K Osborne, W L McGuire, et al.
Molecular Cancer Therapeutics|February 19, 2008
Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signalingAdly Yacoub, Pankaj Gupta, Margaret A Park, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 16, 2013
RETRACTED: Insulin-like growth factor-binding protein-7 (IGFBP7): a promising gene therapeutic for hepatocellular carcinoma (HCC)Dong Chen, Ayesha Siddiq, Luni Emdad, et al.
Molecular Pharmaceutics|May 23, 2018
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast CancerB N Prashanth Kumar, Nagaprasad Puvvada, Shashi Rajput, et al.
Cancer Biology & Therapy|September 13, 2008
Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationMargaret A Park, Guo Zhang, Aditi Pandya Martin, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 12, 2023
A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceSubhayan Das, Moumita Kundu, Atif Hassan, et al.
Drug and Alcohol Dependence|March 15, 2025
A single-blind, randomized, controlled contingency management trial on physiological indices and biomarkers of cardiovascular health in people with cocaine use disorderWilliam W Stoops, Thomas P Shellenberg, Sean D Regnier, et al.
Molecular Cancer Therapeutics|July 29, 2003
MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacityAdly Yacoub, Clint Mitchell, Jessica Brannon, et al.
Plos One|September 21, 2011
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapyLuiz F Zerbini, Rodrigo E Tamura, Ricardo G Correa, et al.
Pageof 203